ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 570

$1.56M Total Retail Price of All Prescriptions

Rank: 9 out of 570

662 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 662 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 15,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 1,713 1,274 1 5
SINGULAIR 1,499 1,193 10 2 15
FLUTICASONE PROPIONATE 1,339 967 10 3 19
PREDNISONE 1,314 946 4 3
ADVAIR DISKUS 1,015 723 5 2
TRAMADOL HCL 802 558 6 31
MONTELUKAST SODIUM 729 517 10 7 29
PROAIR HFA 688 466 8 4
SYMBICORT 594 492 10 9 13
ZOLPIDEM TARTRATE 529 390 10 17
ESCITALOPRAM OXALATE 499 382 11 72
SPIRIVA 407 270 12 1
AZITHROMYCIN 362 266 13 12
QVAR 336 196 14 40
NEXIUM 305 232 15 45
CIPROFLOXACIN HCL 298 221 16 56
FLUOCINONIDE 292 252 17 157
MEGESTROL ACETATE 241 230 R 18 63
LEVOFLOXACIN 236 184 19 32
DULERA 228 186 20 54
COMBIVENT 212 115 21 36
VOLTAREN 200 183 22 165
AMLODIPINE BESYLATE 183 163 23 7
LIDODERM 180 149 24 114
GABAPENTIN 174 163 25 25
VENTOLIN HFA 165 122 26 38
SUCRALFATE 161 100 27 235
SIMVASTATIN 154 130 28 6
HYDROCODONE-ACETAMINOPHEN 152 74 S3 29 9
BACLOFEN 151 131 30 84
AMOX TR-POTASSIUM CLAVULANATE 151 89 30 106
ALENDRONATE SODIUM 142 111 32 28
LEXAPRO 137 108 33 176
NYSTATIN 134 107 34 147
PATANOL 127 108 35 191
NAPROXEN 113 98 36 70
ATORVASTATIN CALCIUM 109 103 37 20
CELEBREX 105 92 38 102
CEPHALEXIN 104 69 39 103
NASONEX 101 74 40 57
METOPROLOL SUCCINATE 96 80 41 44
DIOVAN 96 86 41 27
LOSARTAN POTASSIUM 96 90 41 23
TAMSULOSIN HCL 96 92 41 37
LIDOCAINE 84 77 45 288
DONEPEZIL HCL 84 75 45 35
AMOXICILLIN 83 71 47 133
METFORMIN HCL 76 70 48 14
FLUCONAZOLE 75 52 49 239
IBUPROFEN 74 59 50 53
CLOBETASOL PROPIONATE 73 62 51 300
HYDROCHLOROTHIAZIDE 72 58 52 26
FUROSEMIDE 68 45 53 10
PRAVASTATIN SODIUM 67 55 54 43
METOPROLOL TARTRATE 65 54 55 18
ROPINIROLE HCL 65 35 55 116
PANTOPRAZOLE SODIUM 65 55 55 21
CREON 65 55 55 212
ALLOPURINOL 63 59 59 55
XOPENEX HFA 60 39 60 162
GLIPIZIDE 59 53 61 51
HYDROCORTISONE 58 48 62 225
DOXYCYCLINE HYCLATE 58 35 62 91
ASTEPRO 57 43 64 145
RANITIDINE HCL 53 50 65 88
PROCHLORPERAZINE MALEATE 51 40 66 352
DIOVAN HCT 50 42 67 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.